2019
DOI: 10.1021/acs.joc.9b02111
|View full text |Cite
|
Sign up to set email alerts
|

Recent Changes in the Scaffold Diversity of Organic Chemistry As Seen in the CAS Registry

Abstract: A large set of organic compounds extracted from the CAS Registry is analyzed to study recent changes in structural diversity. The diversity is characterized using the framework content of the compounds; the framework of a molecule is the scaffold consisting of all its ring systems and all the chain fragments connecting them. The compounds are partitioned based on their year of first report in the literature, which allows framework occurrence frequencies to be compared across a 10-year interval. The results are… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
46
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 21 publications
(49 citation statements)
references
References 22 publications
(39 reference statements)
0
46
0
Order By: Relevance
“…To address the lack of 3-dimensionality in pharmaceuticals, there have been efforts in academic and industry laboratories to design and synthesize libraries of 3D molecules to be used in drug discovery campaigns. ,,,,, These structures include compounds prepared through diversity-oriented syntheses with a higher than typical number of sp 3 carbons, as well as chiral and spiro centers. Such strategies are often regarded as possible solutions to the over-representation of flat molecules in fragment libraries and drug discovery feedstocks. ,,,,,, To evaluate the success of such approaches, a PMI analysis (Figure ) was carried out on 15 unique fragments from three different reports (Figure S4). ,, These studies each sought to generate organic fragments with high degrees of 3-dimensionality.…”
Section: Achieving 3-dimensionality In Medicinal Chemistrymentioning
confidence: 99%
“…To address the lack of 3-dimensionality in pharmaceuticals, there have been efforts in academic and industry laboratories to design and synthesize libraries of 3D molecules to be used in drug discovery campaigns. ,,,,, These structures include compounds prepared through diversity-oriented syntheses with a higher than typical number of sp 3 carbons, as well as chiral and spiro centers. Such strategies are often regarded as possible solutions to the over-representation of flat molecules in fragment libraries and drug discovery feedstocks. ,,,,,, To evaluate the success of such approaches, a PMI analysis (Figure ) was carried out on 15 unique fragments from three different reports (Figure S4). ,, These studies each sought to generate organic fragments with high degrees of 3-dimensionality.…”
Section: Achieving 3-dimensionality In Medicinal Chemistrymentioning
confidence: 99%
“…The power functions in logarithmic coordinates are transformed into linear graphs (the example in Figure 1b). These graphs are common for compounds distribution over the frequency of their participation in organic synthesis [8,9] and for the types of molecular fragments distribution over the frequency of their presence in known compounds [10,11]. There are general regularities in such "chemical" frequency distributions, conditionally dividing chemical space into subspaces of more and less popular compounds.…”
Section: Resultsmentioning
confidence: 99%
“…The distribution of ChemSpider database entries over molecular weight was also derived [2]. The statistics of the most common fragments of known chemical compounds have been published, including the distribution of compounds over the number of different fragments [10,11]. Some other statistical data on common compounds can be found in chemical databases (see reviews [12,13]).…”
Section: Introductionmentioning
confidence: 99%
“…The CAS REGISTRY was used to obtain information about the frameworks of each NME in the final data set. This information was extracted from the framework data that CAS algorithmically extracts and systematically stores for every registered substance that meets certain criteria …”
Section: Methodsmentioning
confidence: 99%